Acral lentiginous melanoma and mucosal melanoma expressed less programmed-death 1 ligand than cutaneous melanoma: a retrospective study of 73 Japanese melanoma patients

被引：10
|
作者：
Nakamura, Y. [1 ]
Ishitsuka, Y. [1 ]
Tanaka, R. [1 ]
Okiyama, N. [1 ]
Saito, A. [1 ]
Watanabe, R. [1 ]
Fujisawa, Y. [1 ]
机构：
[1] Univ Tsukuba, Fac Med, Dept Dermatol, Tsukuba, Ibaraki, Japan
来源：
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY | 2019年 / 33卷 / 11期
关键词：
PEMBROLIZUMAB; SURVIVAL;
D O I：
10.1111/jdv.15742
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：E424 / E426
页数：3
相关论文
共 50 条
  • [21] CLINICAL PREDICTORS AND OUTCOMES OF ACRAL LENTIGINOUS MELANOMA PATIENTS: A SINGLE-INSTIUTION RETROSPECTIVE ANALYSIS
    Mantri, S. S.
    Hwang, H. W.
    In, G.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2025, 73 (01) : 691 - 692
  • [22] Acral lentiginous melanoma: a clinicopathologic and genetic study of BRAF status among Tunisian patients
    Sarra, Y.
    El Mabrouk, H.
    Ben Abdelkader, A.
    Ghariani, N.
    Bahri, I.
    Mokni, W.
    Tlili, T.
    Sriha, B.
    Denguezli, M.
    Hmida, D.
    VIRCHOWS ARCHIV, 2024, 485 : S63 - S63
  • [23] Phase 2 study of sunitinib in patients with metastatic mucosal or acral melanoma
    Buchbinder, Elizabeth I.
    Sosman, Jeffrey A.
    Lawrence, Donald P.
    McDermott, David F.
    Ramaiya, Nikhil H.
    Van den Abbeele, Annick D.
    Linette, Gerald P.
    Giobbie-Hurder, Anita
    Hodi, F. Stephen
    CANCER, 2015, 121 (22) : 4007 - 4015
  • [24] FMRP ligand circZNF609 destabilizes RAC1 mRNA to reduce metastasis in acral melanoma and cutaneous melanoma
    Shang, Qingfeng
    Du, Haizhen
    Wu, Xiaowen
    Guo, Qian
    Zhang, Fenghao
    Gong, Ziqi
    Jiao, Tao
    Guo, Jun
    Kong, Yan
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2022, 41 (01)
  • [25] The efficacy of anti-programmed cell death protein 1 therapy among patients with metastatic acral and metastatic mucosal melanoma
    Ogata, Dai
    Haydu, Lauren E.
    Glitza, Isabella C.
    Patel, Sapna P.
    Tawbi, Hussein A.
    McQuade, Jennifer L.
    Diab, Adi
    Ekmekcioglu, Suhendan
    Wong, Michael K.
    Davies, Michael A.
    Amaria, Rodabe N.
    CANCER MEDICINE, 2021, 10 (07): : 2293 - 2299
  • [26] FMRP ligand circZNF609 destabilizes RAC1 mRNA to reduce metastasis in acral melanoma and cutaneous melanoma
    Qingfeng Shang
    Haizhen Du
    Xiaowen Wu
    Qian Guo
    Fenghao Zhang
    Ziqi Gong
    Tao Jiao
    Jun Guo
    Yan Kong
    Journal of Experimental & Clinical Cancer Research, 41
  • [27] Clinical activity of anti -programmed death-1 (PD-1) agents in acral and mucosal melanoma.
    Munhoz, Rodrigo Ramella
    Shoushtari, Alexander Noor
    Kuk, Deborah
    Ott, Patrick Alexander
    Johnson, Douglas Buckner
    Tsai, Katy K.
    Rapisuwon, Suthee
    Eroglu, Zeynep
    Sullivan, Ryan J.
    Luke, Jason John
    Gangadhar, Tara C.
    Salama, April K.
    Clark, Varina
    Burias, Clare
    Puzanov, Igor
    Atkins, Michael B.
    Algazi, Alain Patrick
    Ribas, Antoni
    Wolchok, Jedd D.
    Postow, Michael Andrew
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [28] The use of cytological material in melanoma for programmed death ligand 1 immunostaining
    Bashover, Eva
    Arriola, Aileen Grace
    Joseph, Cicily T.
    Staerkel, Gregg
    Wang, Wei-Lien Billy
    Roy-Chowdhuri, Sinchita
    CYTOPATHOLOGY, 2019, 30 (01) : 61 - 67
  • [29] Clinicopathological and prognostic significance of programmed death ligand 1 expression in Korean melanoma patients
    Yun, S.
    Lee, K.
    Park, Y.
    Moon, S.
    Lee, H. S.
    Choe, G.
    Lee, K. S.
    ANNALS OF ONCOLOGY, 2018, 29
  • [30] Clinicopathological and prognostic significance of programmed death ligand 1 expression in Korean melanoma patients
    Yun, Sumi
    Park, Yujun
    Moon, Seyoung
    Ahn, Soomin
    Lee, Kyoungyul
    Park, Hyo Jin
    Lee, Hye Seung
    Choe, Gheeyoung
    Lee, Kyu Sang
    JOURNAL OF CANCER, 2019, 10 (13): : 3070 - 3078
12345